Previous close | 0.9556 |
Open | 0.9800 |
Bid | 0.0000 x 3200 |
Ask | 0.0000 x 900 |
Day's range | 0.9343 - 0.9800 |
52-week range | 0.8100 - 5.6500 |
Volume | |
Avg. volume | 277,750 |
Market cap | 31.313M |
Beta (5Y monthly) | 0.44 |
PE ratio (TTM) | 1.66 |
EPS (TTM) | 0.5670 |
Earnings date | 08 Aug 2022 - 12 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Kin Communications Inc. ("Kin"), a leading full-service investor relations agency, has joined forces with NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen M.D.''), a leader in needle-free drug delivery, to raise funds in order to purchase insulin to be administered and delivered with NuGen M.D's needle-free injection device also known as InsuJet™, to Ukrainian diabetics urgently in need of daily insulin injections to stay alive.
Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (